menu
    • menu

    Company profile for Deciphera Pharmaceuticals

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Deciphera Pharmaceuticals, we are developing novel drug candidates to improve the lives of cancer patients by addressing key mechanisms of tumor and drug resistance that limit the effectiveness of many cancer therapies. Our pipeline of drug candidates is designed to stop cancers from growing and spreading by inhibiting mutant forms or over expression of a family of enzymes called kinases. Enabled by our proprietary kinase s...
    At Deciphera Pharmaceuticals, we are developing novel drug candidates to improve the lives of cancer patients by addressing key mechanisms of tumor and drug resistance that limit the effectiveness of many cancer therapies. Our pipeline of drug candidates is designed to stop cancers from growing and spreading by inhibiting mutant forms or over expression of a family of enzymes called kinases. Enabled by our proprietary kinase switch control inhibitor platform, we have built a diverse pipeline of wholly-owned, orally administered drug candidates that includes three clinical-stage and two research-stage programs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Deciphera PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Deciphera Pharmaceuticals, Inc. 200 Smith Street Waltham, MA 02451
    Telephone
    Telephone
    781.209.6400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.deciphera.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/deciphera-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Deciphera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Deciphera Presents Positive Phase 2A Sapablursen Results
    Deciphera Presents Positive Phase 2A Sapablursen Results

    06 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251206361611/en/Deciphera-Announces-Oral-Presentation-of-Positive-Topline-Results-from-Phase-2a-Study-of-Sapablursen-in-Polycythemia-Vera-at-the-67th-American-Society-of-Hematology-ASH-Annual-Meeting

    BUSINESSWIRE
    06 Dec 2025
    Share Share
    Deciphera Announces Opening of a New Office in Zug, Switzerland
    Deciphera Announces Opening of a New Office in Zug, Switzerland

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251116010869/en/Deciphera-Announces-the-Opening-of-a-New-Office-in-Zug-Switzerland

    BUSINESSWIRE
    17 Nov 2025
    Share Share
    Deciphera Unveils Multiple Data at CTOS Annual Meeting 2025
    Deciphera Unveils Multiple Data at CTOS Annual Meeting 2025

    12 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251112742665/en/Deciphera-Announces-Multiple-Data-Presentations-at-the-Connective-Tissue-Oncology-Society-CTOS-Annual-Meeting-2025

    BUSINESSWIRE
    12 Nov 2025
    Share Share
    Deciphera Gets EU Approval for Romvimza to Treat TGCT Tumor
    Deciphera Gets EU Approval for Romvimza to Treat TGCT Tumor

    17 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-17/deciphera-receives-european-commission-approval-of-romvimza-vimseltinib-for-the-treatment-of-teno

    PHARMAWEB
    17 Sep 2025
    Share Share
    Deciphera's Romvimza Gets Positive CHMP Opinion for TGCT
    Deciphera's Romvimza Gets Positive CHMP Opinion for TGCT

    28 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250725009938/en/Deciphera-Announces-Positive-CHMP-Opinion-for-ROMVIMZA-vimseltinib-for-the-Treatment-of-Tenosynovial-Giant-Cell-Tumor-TGCT

    BUSINESSWIRE
    28 Jul 2025
    Share Share
    Onco360 Chosen as National Specialty Pharmacy for QinlocK
    Onco360 Chosen as National Specialty Pharmacy for QinlocK

    20 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/20/3102647/0/en/Onco360-Has-Been-Selected-as-a-National-Specialty-Pharmacy-Partner-for-QINLOCK-ripretinib.html

    GLOBENEWSWIRE
    20 Jun 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search